Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 223,849 | 171,174 | 170,412 | 216,500 | 187,924 |
| Marketable Securities | 68,709 | 123,212 | 114,835 | 62,144 | 46,262 |
| Receivables | 147,485 | 157,453 | 160,727 | 148,873 | 134,585 |
| Inventories | 179,907 | 170,194 | 176,890 | 185,932 | 191,731 |
| TOTAL | $630,951 | $633,683 | $636,016 | $639,470 | $580,830 |
| Non-Current Assets | |||||
| PPE Net | 316,063 | 307,231 | 310,567 | 308,689 | 310,239 |
| Investments And Advances | 0 | 0 | 0 | 0 | 2,047 |
| Other Non-Current Assets | 796,752 | 707,248 | 682,716 | 718,063 | 722,217 |
| TOTAL | $1,112,815 | $1,014,479 | $993,283 | $1,026,752 | $1,034,503 |
| Total Assets | $1,743,766 | $1,648,162 | $1,629,299 | $1,666,222 | $1,615,333 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,488 | 1,671 | 1,641 | 923 | 927 |
| Accounts payable and accrued liabilities | 251,371 | 152,688 | 148,348 | 190,844 | 166,552 |
| TOTAL | $263,205 | $164,478 | $158,156 | $205,227 | $176,407 |
| Non-Current Liabilities | |||||
| Long Term Debt | 609,564 | 609,801 | 608,749 | 608,582 | 607,727 |
| Other Non-Current Liabilities | 102,840 | 100,492 | 73,589 | 75,667 | 73,717 |
| TOTAL | $712,404 | $710,293 | $682,338 | $684,249 | $681,444 |
| Total Liabilities | $975,609 | $874,771 | $840,494 | $889,476 | $857,851 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,538 | 44,093 | 45,370 | 45,952 | 46,495 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | 703,649 | 673,301 | 666,881 | 642,451 | 625,102 |
| Other shareholders' equity | -5,500 | -5,732 | -5,462 | -4,926 | -5,207 |
| TOTAL | $768,157 | $773,391 | $788,805 | $776,746 | $757,482 |
| Total Liabilities And Equity | $1,743,766 | $1,648,162 | $1,629,299 | $1,666,222 | $1,615,333 |